Should we include ONLY clinical trial data? Or is it worth having data from other pharma-related disciplines?

[MikeKSmith-Pfizer]

If we're going to use the PhUSE synthetic datasets (under MIT license) then the examples will be mostly focussed on clinical trial data. While this might be useful for the majority of programmers who want to learn tidyverse as a transition from using SAS, it might be nice to widen the net to use data from pre-clinical, safety, manufacturing, pharmaceutical sciences etc.